The report “Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts
Tag:- Human insulin market
MarketsandMarkets™ - Dec 01, 2018
Human Insulin Market worth $ 39.13 Billion by 2020
MarketsandMarkets™ - Nov 24, 2018
“Safety needles segment is expected to witness fastest market growth among human insulin delivery devices in coming years”
MarketsandMarkets™ - Nov 16, 2018
The Global Human Insulin Market is highly consolidated with few Tier I players
MarketsandMarkets™ - Sep 12, 2018
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - Sep 07, 2018
“Safety needles segment is expected to witness fastest market growth among human insulin delivery devices in coming years”
MarketsandMarkets™ - Sep 01, 2018
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - Aug 05, 2018
Human Insulin Market by Drugs & Applications - 2020
MarketsandMarkets™ - Mar 29, 2018
Human Insulin Market by Drugs & Applications - 2020
MarketsandMarkets™ - Nov 06, 2017
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - Jul 25, 2017
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - Jul 20, 2017
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - Jul 01, 2017
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - Jun 25, 2017
Human Insulin Market by Drugs & Applications
MarketsandMarkets™ - May 27, 2017
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - May 22, 2017
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - May 12, 2017
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - Apr 07, 2017
Human Insulin Market worth 39.13 Billion USD by 2020
MarketsandMarkets™ - Mar 25, 2017